{"id":28657,"date":"2025-05-29T13:05:15","date_gmt":"2025-05-29T13:05:15","guid":{"rendered":"http:\/\/medexperts.pro\/?p=28657"},"modified":"2025-05-29T13:33:16","modified_gmt":"2025-05-29T13:33:16","slug":"the-times-and-amazon-announce-a-i-licensing-deal","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=28657","title":{"rendered":"The Times and Amazon Announce A.I. Licensing Deal"},"content":{"rendered":"
<\/div>\n

In 2023, The Times sued OpenAI and Microsoft for copyright infringement. Now its editorial content will appear across Amazon platforms.<\/p>\n

\n
\n
\n

The New York Times Company has agreed to license its editorial content to Amazon for use in the tech giant\u2019s artificial intelligence platforms, the company said on Thursday.<\/p>\n

The agreement \u201cwill bring Times editorial content to a variety of Amazon customer experiences,\u201d the news organization said in a statement. Besides news articles, the agreement also encompasses material from NYT Cooking, The Times\u2019s food and recipe site, and The Athletic, which focuses on sports.<\/p>\n

This is the first instance of The Times agreeing to a licensing arrangement with a focus on generative A.I. technology.<\/p>\n

In 2023, The Times sued OpenAI<\/a> and its partner, Microsoft, for copyright infringement, accusing the tech companies of using millions of articles published by The Times to train automated chatbots without any kind of compensation. OpenAI and Microsoft have rejected those accusations.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

Financial terms of the licensing deal with Amazon were not disclosed.<\/p>\n

\u201cThe deal is consistent with our long-held principle that high-quality journalism is worth paying for,\u201d Meredith Kopit Levien, the chief executive of The Times, said in a note to staff. \u201cIt aligns with our deliberate approach to ensuring that our work is valued appropriately, whether through commercial deals or through the enforcement of our intellectual property rights.\u201d<\/p>\n

Amazon\u2019s use of editorial content from The Times could extend to the Alexa software found on its smart speakers. Material from The Times will also be used to train Amazon\u2019s proprietary A.I. models, the company said.<\/p>\n

This is a developing story. Check back for updates.<\/em><\/p>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

In 2023, The Times sued OpenAI and Microsoft for copyright infringement. Now its editorial content will appear across Amazon platforms.The New York Times Company has agreed to license its editorial content to Amazon for use in the tech giant\u2019s artificial intelligence platforms, the company said on Thursday.The agreement \u201cwill bring Times editorial content to a variety of Amazon customer experiences,\u201d the news organization said in a statement. Besides news articles, the agreement also encompasses material from NYT Cooking, The Times\u2019s food and recipe site, and The Athletic, which focuses on sports.This is the first instance of The Times agreeing to a licensing arrangement with a focus on generative A.I. technology.In 2023, The Times sued OpenAI and its partner, Microsoft, for copyright infringement, accusing the tech companies of using millions of articles published by The Times to train automated chatbots without any kind of compensation. OpenAI and Microsoft have rejected those accusations.Financial terms of the licensing deal with Amazon were not disclosed.\u201cThe deal is consistent with our long-held principle that high-quality journalism is worth paying for,\u201d Meredith Kopit Levien, the chief executive of The Times, said in a note to staff. \u201cIt aligns with our deliberate approach to ensuring that our work is valued appropriately, whether through commercial deals or through the enforcement of our intellectual property rights.\u201dAmazon\u2019s use of editorial content from The Times could extend to the Alexa software found on its smart speakers. Material from The Times will also be used to train Amazon\u2019s proprietary A.I. models, the company said.This is a developing story. Check back for updates.<\/p>\n","protected":false},"author":1,"featured_media":28659,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-28657","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/28657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28657"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/28657\/revisions"}],"predecessor-version":[{"id":28660,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/28657\/revisions\/28660"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/28659"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28657"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28657"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}